论文部分内容阅读
近两年来,我们对门诊及部分住院的间日疟患者,采用磺胺甲氧嗪(SMP)+甲氧苄氨嘧啶(TMP)治疗,取得了很好的效果。方法:SMP0.5+ThP0.1-0.2,每日二次口服,服三天。此为成人剂量,儿童按公斤体重酌减。结果:治疗23例,均在服药的第一日后即控制症状发作,除一例14岁男孩治疗后一个月左右复发(该例已经过多次正规治疗量的氯喹啉与伯氨喹,未根治,并血片中找到疟原虫,是否对氯喹啉与伯氨喹耐药,不能定论),余未见复发,但限于当时的条件,未作疟原虫消失情况观察。23例均未发现副作用。另外,我们曾对部分病例单用TMP和增效新明磺(SMZ+TMP)治疗间日疟,效果均不
In the past two years, we have achieved good results in the out-patient clinic and some hospitalized patients suffering from vivaxergic sulfamethoxazole (SMP) + trimethoprim (TMP). Methods: SMP0.5 + ThP0.1-0.2 orally twice daily for three days. This is an adult dose, children reduce weight by kilogram. Results: The treatment of 23 cases, both in the first day after taking the medication to control the onset of symptoms, except for a 14-year-old boy relapsed about a month after treatment (the case has been over the regular treatment of the amount of chloroquine and primaquine, no cure, And found in the blood film of Plasmodium, whether chloroquine and primaquine resistance, can not be conclusive), I no recurrence, but limited to the conditions at the time, not for the disappearance of malaria parasites observed. 23 cases were found no side effects. In addition, we have used some of the cases of TMP and synergistic neostigma (SMZ + TMP) treatment of P. vivax, the effect is not